The Hospital Pharmacy Segment held the Largest Share of the Drug Addiction Treatment Market in 2021
According to Custom Market Insights (CMI), the Global Drug Addiction Treatment Market size was estimated at USD 16.5 Billion in 2021 and is expected to hit around USD 35 Billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 15% from 2022 to 2030. Our research report offers a 360-degree view of the Drug Addiction Treatment market’s drivers and restraints, coupled with the impact they have on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Drug Addiction Treatment market.
Drug Addiction Treatment Market: Overview
Drug addiction is a condition that alters a person’s behavior and brain function. Despite being aware of the risks associated with drug usage, a person addicted to a substance struggles to resist the temptation to use it. The disease is more complicated than using cocaine, heroin, or other illegal drugs. The illness may also be brought on by addiction to nicotine, opiate medicines, alcohol, and other legal substances. Continuous exposure to these medications impairs their brain function, making it difficult for them to resist the impulse to consume the drugs. The indicated alteration in how the brain functions take place gradually over time. It could cause people to lose their self-control and engage in harmful actions. Depending on the substance being used, an individual’s level of addiction or rate of addiction development will vary.
Browse the full “Drug Addiction Treatment Market Size, Trends and Insights By Treatment Centers (Residential Centers, Rehabilitation centers, Inpatient Centers, Others), By Drug Type (Tobacco/Nicotine and Vaping, Marijuana, Alcohol, Prescription and Over-the-Counter Medications, Synthetic Cannabinoids, Others), By Distribution Channel (Medical Stores, Hospital Pharmacies, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032 “ report at https://www.custommarketinsights.com/report/drug-addiction-treatment-market/
The market for drug addiction treatment is anticipated to develop profitably between 2022 and 2030, driven by an increase in the prevalence of drug, alcohol, and tobacco abuse. It is well known that the excessive ingestion of these substances harms the human body.
Additionally, during the forecast period of 2022–2030, rising public awareness of the harmful effects of substance misuse, the launch of new programs, and the expansion of rehabilitation facilities globally will all assist the growth of the global drug addiction treatment market. By providing national leadership in the development of programs, policies, and services to slow the onset of substance misuse, for instance, SAMHSA’s Center for Substance Abuse Prevention works to create complete systems.
Additionally, a growing number of treatment facilities that have alliances with for-profit rehabilitation facilities are entering the market, resulting in a prodigious expansion of treatment access to a larger population.
During the course of the analysis period, growth challenges for the global drug addiction treatment market are anticipated due to factors including the high level of individual resistance to treatment access due to the associated social stigma and termination of therapies leading to relapse of addiction.
The market for Drug Addiction Treatment is segmented into drug type, treatment center, and distribution channel. Based on the distribution channel, the hospital pharmacy segment is anticipated to contribute significantly to revenue. This segment’s revenue growth is mostly attributable to the hospital pharmacists’ accessibility to treatments and drugs tailored to specific disorders. For patients with substance use disorders to have easier access to medications, hospital pharmacists make drugs like the opioid analgesic naloxone freely available. Between 2022 and 2030, increased consumer awareness about the availability of medications in hospital pharmacies will also contribute to this segment’s revenue growth.
Rehabilitation programs are making significant progress overall in addressing the population with the worst influence over substance abuse, based on application. Programs for restoration help people take back control of their lives and reintegrate into society. Victims are guided by drug rehabilitation centers using 12-step programs, such as support groups. Additionally, the involvement of regional leaders in the creation of new addiction rehabilitation programs will soon also stimulate the market’s growth curve.
North America held the largest market share for drug addiction treatment worldwide in 2021. This is because there are more smokers in the country, which has led to health problems for both active and passive smokers. Growing adoption of addiction treatment programs, particularly for quitting tobacco usage, and a solid healthcare infrastructure are anticipated to boost market prospects. The area is anticipated to hold more than two-fifths of the global market for drug addiction treatment, and it is anticipated to expand at a rate of 1.4x during the projected period.
|Feature of the Report||Details|
|Market Size in 2021||USD 16.5 Billion|
|Projected Market Size in 2030||USD 35 Billion|
|Market Size in 2022||USD 18.5 Billion|
|CAGR Growth Rate||15% CAGR (2022-2030)|
|Prominent Players||Alkermes Plc., Glenmark Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc., Perrigo Company plc., Cipla Limited, Dr. Reddy’s Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., and Others|
|Key Segment||By Treatment Centers, Drug Type, Distribution Channel, and Region|
|Report Coverage||Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends|
|Regional Scope||North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America|
|Buying Options||Request tailored purchasing options to fulfil your requirements for research.|
Our market analysis includes a section specifically devoted to key players operating in the Drug Addiction Treatment market. Our analysts give an overview of each player’s financial statements, along with product benchmarking and SWOT analysis. The competitive landscape section includes key development strategies, market share analysis, and market positioning analysis of the mentioned competitors globally.
- 2021: The biotechnology company AELIS FARMA, which specializes in treating brain disorders, announced crucial cooperation and choice permit agreement with INDIVIOR PLC to address the major consequences of marijuana use problems (CUD), including marijuana-induced psychosis (CIP).
- 2021: The Ridge is opening a new location to provide people who suffer from the negative consequences of drug and alcohol enslavement with restrictive private medication.
- Alkermes Plc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Titan Pharmaceuticals Inc.
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline plc.
- Perrigo Company plc.
- Cipla Limited
- Reddy’s Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
The global Drug Addiction Treatment market is segmented as follows:
By Treatment Centers
- Residential Centers
- Rehabilitation centers
- Inpatient Centers
By Drug Type
- Tobacco/Nicotine and Vaping
- Prescription and Over-the-Counter Medications
- Synthetic Cannabinoids
By Distribution Channel
- Medical Stores
- Hospital Pharmacies
- The U.S.
- The UK
- Rest of Europe
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Rest of Latin America